I appreciate your personalized customer service and prompt follow up. All I can say is this, if you are this straight forward and direct when something goes wrong, then you treat your customers with respect. And if you do that on a regular basis, you deserve to have great things happen to you in the future.
I will be in touch.
Thanks.
Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South Korea - MarketWatch (press release)
Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South KoreaMarketWatch (press release)Silenor is a low-dose (3 mg and 6 mg) oral tablet formulation of doxepin, and is the first and only non-scheduled prescription sleep medication approved to treat insomnia characterized by difficulties with sleep maintenance.
Infinite Itch: Learning to Live With Hives - New York Times (blog)
New York Times (blog)Infinite Itch: Learning to Live With HivesNew York Times (blog)But doxepin, the drug that finally suppressed the hives, made him so sleepy that he repeatedly dozed off on a desk during six weeks of job training.
Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South Korea - SunHerald.com
SunHerald.
Somaxon, CJ CheilJedang sign Silenor commercialization agreement - Pharmaceutical Business Review
Somaxon, CJ CheilJedang sign Silenor commercialization agreementPharmaceutical Business ReviewSomaxon Pharmaceuticals and CJ CheilJedang have signed a commercialization agreement in South Korea for Silenor (doxepin) to treat insomnia.
Paladin Reports First Quarter 2012 Results Achieves Record Revenues - MarketWatch (press release)
Paladin Reports First Quarter 2012 Results Achieves Record RevenuesMarketWatch (press release)Silenor(R) is a low-dose oral tablet formulation of doxepin indicated for the treatment and symptomatic relief of insomnia.